After retreating from many leading biotech and emerging pharmaceutical stocks in the previous two periods, short sellers returned in early March, especially in Celgene, Medivation and Pharmacyclics.
via Business News - Yahoo Finance http://ift.tt/1gDfTXx
0 commentaires:
Enregistrer un commentaire